Fortrea Holdings (FTRE) said late Wednesday it appointed Anshul Thakral as chief executive officer and a director of the board, starting August 4.
Thakral succeeds interim CEO Peter M. Neupert, who will retain his role as board chairman, according to a statement.
Thakral was most recently the CEO of Launch Therapeutics, the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.